On 22nd February 2023, PTC Therapeutics, Ltd. announced the National Institute for Health and Care Excellence (NICE) has published its Final Guidance recommending Translarna™ (ataluren) for reimbursement and use across the National Health Service (NHS) in England and Wales. Translarna is the only approved treatment for patients with nonsense mutation Duchenne muscular dystrophy aged 2 years and older who can…
Category: NHS News
Indoor way-finder launched at Chelsea & Westminster Hospital NHS Foundation Trust
BuzzStreets and Chelsea & Westminster Hospital NHS Foundation Trust are launching a unique indoor way-finder for hospitals to help patients and their families navigate their way around more easily, reduce staff time spent giving directions, help ensure patients arrive on time for appointments, reduce stress, and minimise traffic in the corridors. Research has shown that…
